Emerald Advisers, Llc
Source: SEC Form 13F · as of Mar 2026Emerald Advisers, Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $322.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$322.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Cogent Biosciences, Inc. (COGT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| COGTCogent Biosciences, Inc. | 1,588,132 | $61.1M |
| TVTXTravere Therapeutics, Inc. | 1,557,196 | $46.3M |
| BBIOBridgeBio Pharma, Inc. | 515,361 | $38.3M |
| SYRESpyre Therapeutics, Inc. | 613,365 | $30.9M |
| NKTRNEKTAR THERAPEUTICS | 394,604 | $28.4M |
| KALVKalVista Pharmaceuticals, Inc. | 1,264,023 | $25.4M |
| PVLAPALVELLA THERAPEUTICS, INC. | 161,500 | $20.1M |
| SVRASavara Inc | 3,371,285 | $18.4M |
| AXSMAxsome Therapeutics, Inc. | 107,610 | $18.2M |
| CYTKCYTOKINETICS INC | 198,811 | $13.1M |
| SLNOSOLENO THERAPEUTICS INC | 274,138 | $9.2M |
| MANEVeradermics Incorporated | 132,536 | $8.4M |
| INSMINSMED Inc | 11,990 | $2.0M |
| TEVATeva Pharmaceutical Industries Limited | 34,289 | $1.0M |
| ACADACADIA PHARMACEUTICALS INC | 28,637 | $637K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,622 | $537K |
| OCULOCULAR THERAPEUTIX, INC | 20,768 | $176K |
| IVVDInvivyd, Inc. | 89,938 | $117K |
| ANIPANI PHARMACEUTICALS INC | 1,256 | $97K |
| BHVNBiohaven Ltd. | 11,088 | $94K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.